Threat actors are exploiting complex routing scenarios and misconfigured spoof protections to send spoofed phishing emails, ...

Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...

Some stories, though, were more impactful or popular with our readers than others. This article explores 15 of the biggest ...